Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Dusseldorf - Delayed Quote EUR

Lineage Cell Therapeutics Inc (BT3.DU)

Compare
0.3600
-0.0100
(-2.70%)
At close: 7:31:22 PM GMT+2
Loading Chart for BT3.DU
  • Previous Close 0.3700
  • Open 0.3580
  • Bid 0.3560 x --
  • Ask 0.3740 x --
  • Day's Range 0.3560 - 0.3600
  • 52 Week Range 0.3320 - 1.2100
  • Volume 0
  • Avg. Volume 47
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: BT3.DU

View More

Performance Overview: BT3.DU

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BT3.DU
26.23%
S&P 500 (^GSPC)
10.18%

1-Year Return

BT3.DU
69.23%
S&P 500 (^GSPC)
5.19%

3-Year Return

BT3.DU
69.75%
S&P 500 (^GSPC)
20.26%

5-Year Return

BT3.DU
69.75%
S&P 500 (^GSPC)
83.77%

Compare To: BT3.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BT3.DU

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    84.29M

  • Enterprise Value

    44.18M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.81

  • Price/Book (mrq)

    1.22

  • Enterprise Value/Revenue

    5.25

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BT3.DU

View More

Company Insights: BT3.DU

Research Reports: BT3.DU

View More